DAVENPORT & Co LLC Invests $1.29 Million in SPDR S&P Biotech ETF $XBI

DAVENPORT & Co LLC acquired a new position in SPDR S&P Biotech ETF (NYSEARCA:XBI) during the 4th quarter, HoldingsChannel reports. The fund acquired 10,536 shares of the exchange traded fund’s stock, valued at approximately $1,285,000.

Several other large investors have also bought and sold shares of XBI. Capital A Wealth Management LLC acquired a new position in SPDR S&P Biotech ETF during the 2nd quarter worth about $26,000. Davis Capital Management bought a new stake in shares of SPDR S&P Biotech ETF in the 3rd quarter valued at about $35,000. Twin Peaks Wealth Advisors LLC acquired a new stake in shares of SPDR S&P Biotech ETF in the second quarter valued at about $32,000. Johnson Financial Group Inc. bought a new position in shares of SPDR S&P Biotech ETF during the second quarter worth about $31,000. Finally, Halbert Hargrove Global Advisors LLC bought a new position in shares of SPDR S&P Biotech ETF during the third quarter worth about $40,000.

SPDR S&P Biotech ETF Stock Performance

Shares of NYSEARCA XBI opened at $119.59 on Monday. SPDR S&P Biotech ETF has a 52-week low of $66.66 and a 52-week high of $132.09. The company’s 50 day moving average price is $125.08 and its 200-day moving average price is $117.41. The company has a market capitalization of $7.99 billion, a P/E ratio of 11.47 and a beta of 0.93.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.